ResearchMoz

Caprolactam Industry Outlook in Spain to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants

GlobalData
Published Date » 2012-04-25
No. Of Pages » 33
   
   
 GlobalDatas report, Caprolactam Industry Outlook in Spain to 2016 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Spain Caprolactam industry. The research presents major market trends affecting the Caprolactam industry in Spain. The report covers Spain Caprolactam plants and presents installed capacity by key feedstock, process and technology. In addition, it presents Caprolactam demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Caprolactam producers in Spain. Overall, the report presents a comprehensive coverage of Spain Caprolactam industry including all the major parameters. 
   
  Scope  
   
 
 
 Caprolactam...
Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4

2 Spain Caprolactam Industry, Supply Scenario, 2000-2016 5
2.1 Spain Caprolactam Industry, Total Plant Capacity, 2000-2016 5
2.2 Spain Caprolactam Industry, Installed Plant Capacity by Key Feedstock, 2011 8
2.3 Spain Caprolactam Industry, Installed Plant Capacity by Production Process, 2011 8
2.4 Spain Caprolactam Industry, Company Share, 2011 8

3 Spain Caprolactam Industry, Market Dynamics, 2000-2016 9
3.1 Spain Caprolactam Industry, Market Size, 2000-2016 9
3.2 Spain Caprolactam Industry, Demand and Production Outlook, 2000-2016 11
3.3 Spain Caprolactam Industry, Demand by End Use Sector, 2011 13
3.4 Spain Caprolactam Industry, Price Forecasts, 2000-2016 14

4 Spain Caprolactam Industry, Trade Balance, 2000-2016 16
4.1 Spain Caprolactam Industry, Imports and Exports, 2000-2016 16
4.2 Spain Caprolactam Industry, Net Exports, 2000-2016 18
4.3 Spain Caprolactam Industry, Imports as Percentage of Demand, 2000-2016 20

5 Ube Industries, Ltd., Company Snapshot 22
5.1 Ube Industries, Ltd., Company Overview 22
5.2 Ube Industries, Ltd., Key Information 22
5.3 Ube Industries, Ltd., Business Description 22
5.3.1 Business Overview 22
5.4 Ube Industries, Ltd., Caprolactam Market, 2011 25
5.4.1 Ube Industries, Ltd., Caprolactam Capacity Split, Spain and Rest of the World, 2011 25
5.4.2 Ube Industries, Ltd., Caprolactam Plant Capacity Share in the Spain, 2011 25
5.4.3 Ube Industries, Ltd., Caprolactam Capacity in the Spain, 2000-2016 25
5.4.4 Ube Industries, Ltd., Caprolactam Plants Details in the Spain, 2011 25
5.5 SWOT Analysis 26
5.5.1 Overview 26
5.5.2 Ube Industries, Ltd. Strengths 26
5.5.3 Ube Industries, Ltd. Weaknesses 28
5.5.4 Ube Industries, Ltd. Opportunities 28
5.5.5 Ube Industries, Ltd. Threats 29

6 Appendix 31
6.1 Definitions 31
6.1.1 Installed Plant Capacity 31
6.1.2 Key Feedstock 31
6.1.3 Process 31
6.1.4 Technology 31
6.2 Abbreviations 31
6.3 GlobalDatas Methodology 31
6.3.1 Coverage 31
6.3.2 Secondary Research 32
6.3.3 Primary Research 32
6.3.4 Expert Panel Validation 33
6.4 Contact Us 33
6.5 Disclaimer 33

List of Tables

 
Table 1: Spain, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 6
Table 2: Spain, Caprolactam Plants Capacity, MMTPA, 2000-2016 6
Table 3: Spain, Active Caprolactam Plants Details, MMTPA, 2011 6
Table 4: Spain, Active Caprolactam Plants by Key Feedstock, Process and Technology, 2011 7
Table 5: Spain, Top Caprolactam Plants Details, 2011 7
Table 6: Spain, Caprolactam Industry, Demand Value, $m, 2000-2016 10
Table 7: Spain, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 12
Table 8: Spain, Butadiene Industry, Demand by End Use Sector, %, 2011 13
Table 9: Spain, Caprolactam Industry, Price Forecasts, 2000-2016 15
Table 10: Spain, Caprolactam Industry, Imports and Exports , MMTPA, 2000-2016 17
Table 11: Spain, Caprolactam Industry, Net Exports, MMTPA, 2000-2016 19
Table 12: Spain, Caprolactam Industry, Imports as Percentage of Demand, %, 2000-2016 21
Table 13: Ube Industries, Ltd., Key Facts 22
Table 14: Spain, Ube Industries, Ltd., Caprolactam Plant Capacity, MMTPA, 2000-2016 25
Table 15: Spain, Ube Industries, Ltd. Caprolactam Plants Details, 2011 25
Table 16: Ube Industries, Ltd., SWOT Analysis 26

List of Figures

 
Figure 1: Spain, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 5
Figure 2: Spain, Caprolactam Industry, Demand Value, $m, 2000-2016 9
Figure 3: Spain, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 11
Figure 4: Spain, Caprolactam Industry, Demand by End Use Sector, %, 2011 13
Figure 5: Spain, Caprolactam Industry, Price Forecasts, $/Tonne, 2000-2016 14
Figure 6: Spain, Caprolactam Industry, Imports and Exports, MMTPA, 2000-2016 16
Figure 7: Spain, Caprolactam Industry, Net Exports, MMTPA, 2000-2016 18
Figure 8: Spain, Caprolactam Industry, Imports as Percentage of Demand, %, 2000-2016 20

Upcoming Reports:

Oral Proteins And Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Pharmaceutical formulations containing proteins and peptides are usually administered via intravenous or subcutaneous route of administration, because instability and sensitivity towards body fluids. However, owing to rising R&D activities and technological advancements, the researchers have successfully developed protein formulations that are orally administered with no change in therapeutic activity and pharmacokinetic aspects.The market for oral proteins and peptides is expected to show a promising growth, owing to continuous research and development activities, technological...
B-Type Natriuretic Peptide Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
B-type natriuretic peptides, also called, brain natriuretic peptide, is a 32-amino acid (AA) polypeptide, which is produced by ventricles of the heart, as a reflex action to over-stretching of cardiac muscles cells. The generation of BNP is controlled by calcium ions. BNP and ANP (atrial natriuretic peptide) are working similarly and the physiological action of both is similar. The important function of ANP and BNP is to decrease the systemic vascular resistance, which leads to decrease of blood volume, thus results in decrease in blood pressure and increase in cardiac output. BNP...
Bone and Joints Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Bone and joints ingredients are those elements which are taken as supplement in order to maintain healthy bones and joints. These value added ingredients help in increasing the strength and flexibility of the bones and joints in the body. There are various bone and joint ingredients including calcium, soy isoflavone and collagen. For instance, calcium is the most popular bone ingredient. It is an established ingredient with a mature market. Soy isoflavone is another key bone health ingredient maintaining bone mineral density (BMD) and preventing bone loss. The most important...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...